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Replacement of Nitrite in Meat Products by Natural
Bioactive Compounds Results in Reduced Exposure to
N-Nitroso Compounds: The PHYTOME Project
Simone G. van Breda,* Karen Mathijs, Harm-Jan Pieters, Virág Sági-Kiss,
Gunter G. Kuhnle, Panagiotis Georgiadis, Giovanna Saccani, Giovanni Parolari,
Roberta Virgili, Rashmi Sinha, Gert Hemke, Yung Hung, Wim Verbeke, Ad A. Masclee,
Carla B. Vleugels-Simon, Adriaan A. van Bodegraven, Theo M. de Kok, and on behalf of
the PHYTOME consortium
Scope: It has been proposed that endogenously form N-nitroso compounds
(NOCs) are partly responsible for the link between red meat consumption
and colorectal cancer (CRC) risk. As nitrite has been indicated as critical
factor in the formation of NOCs, the impact of replacing the additive sodium
nitrite (E250) by botanical extracts in the PHYTOME project is evaluated.
Method and Results: A human dietary intervention study is conducted in
which healthy subjects consume 300 g of meat for 2 weeks, in subsequent
order: conventional processed red meat, white meat, and processed red meat
with standard or reduced levels of nitrite and added phytochemicals.
Consumption of red meat products enriched with phytochemicals leads to a
significant reduction in the faecal excretion of NOCs, as compared to
traditionally processed red meat products. Gene expression changes identify
cell proliferation as main affects molecular mechanism. High nitrate levels in
drinking water in combination with processed red meat intake further
stimulates NOC formation, an effect that could be mitigated by replacement
of E250 by natural plant extracts.
Conclusion: These findings suggest that addition of natural extracts to
conventionally processed red meat products may help to reduce CRC risk,
which is mechanistically support by gene expression analyses.
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The safety of processed meat consump-
tion is being debated already for many
years. According to several reports of the
World Cancer Research Fund,[1,2] there is
convincing evidence that the consump-
tion of red and particularly processed
meat is associated with cancer risk. Ad-
ditionally, the International Agency on
Research on Cancer has classified pro-
cessed meat as carcinogenic to humans
(Group 1 carcinogen), based on sufficient
evidence in humans that the consump-
tion of processed meat causes colorectal
cancer (CRC).[3] Others argue however,
that meat and meat products form a con-
ventional part of the human diet and also
contribute to the health of consumers
in view of the supply of essential amino
acids, iron, zinc, selenium, vitamin B6
and B12, and vitamin D. According to
Hodgson et al.,[4] the consumption of red
meat also results in a reduced blood pres-
sure and may thus contribute to reduced
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risk of cardiovascular diseases. As a consequence, there has been
quite some debate on how to reach consensus on the healthiness
of red and processed meat.[5]
In order to find a mechanistic explanation for the link be-
tween meat consumption and CRC risk, the formation of food
preparation-related compounds, such as heterocyclic amines
(HCAs) and polycyclic aromatic hydrocarbons (PAHs), have
been investigated. Also the exposure to endogenously formed N-
nitroso compounds (NOCs) has been suggested as a potentially
relevant risk factor since red meat is known to stimulate NOC
formation in the colon.[6–9] Meat in general is a source of NOC
precursors in the form of amines and amides, and nitrate and ni-
trite in particularly salt-preserved meat.[10] Furthermore, haem
protein present in red meat is found to catalyse endogenous
nitrosation.[9,11] In addition, meat products, and especially pro-
cessed meat products, already contain pre-formed NOCs.[12] As
most NOCs havemutagenic and genotoxic properties, explaining
their carcinogenic effect in test animals,[13] they may also con-
tribute to CRC development in humans. However, evidence from
epidemiological studies is inconsistent and methodological is-
sues are apparent. In particular, quantifying individual exposure
to NOCs is difficult. In addition, the presence of other dietary
variables that can affect the formation of NOCs, such as intake of
amines and amides, vegetables and fibre, are not taken into ac-
count. Also, studies often do not control for confounding factors
such as haem iron and saturated fat.[14,15] Furthermore, genetic
variation in the study population could result in differences in re-
sponses to meat consumptions and long-term CRC risk, which
could explain the observed inconsistencies.[15] Moreover, gene
expression changes associated with NOC exposure could play a
part in the carcinogenic process. Indeed, human dietary interven-
tion studies have shown that red meat intake-induced faecal wa-
ter genotoxicity correlate with pro-carcinogenic gene expression
changes in human colonic tissue.[16–19]
Nitrite is added to meat to control the growth of pathogenic
bacteria, to prevent rancidity, and to create the characteristic pink
color of cured meats that is appreciated by consumers.[20–22] In
view of its role in the formation of NOCs, the use of nitrite in
meat products is limited by the European Commission to a max-
imumof 150 ppm.[21] In order to find alternativemeat processing
techniques that limit the use of nitrite while guaranteeing micro-
biological safety, the PHYTOME project (www.phytome.eu) ex-
plores the use of biologically active compounds from botanical
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sources, to replace or reduce nitrite in meat processing.[23] These
biologically active compounds, also referred to as phytochemi-
cals, may have antimicrobial activity, and include a wide range
of chemical classes such as tocopherols, flavonoids, carotenoids,
glycol alkaloids, and vitamins, all from natural sources. These
compounds may exert their beneficial action via different mech-
anisms, including the inhibition of the formation of NOC, ef-
fects at the level of kinetics of carcinogenic compounds in the
colon, and at the level of cellular protection.[24–26] Due to syn-
ergistic interactions, specific combinations may be more effec-
tive than single compounds.[27,28] Some of these compounds also
possess antimicrobial activity and may therefore contribute to
microbiological safety of the product.[29] Natural compounds are
also known to protect the gut from the induction of for instance
oxidative genetic damage by other dietary factors.[27,28,30] In or-
der to replace or reduce nitrite in processed meat without los-
ing their properties, many scientific studies have been carried
out the last 20 years, and several have shown that the use of bi-
ologically active compounds is promising. It was demonstrated
that essential oils containing several bioactive compounds such
as eugenol and cinnamaldehyde possess antimicrobial activity
while added to freshmeat andmeat products.[31] In addition, spe-
cific antioxidants such as grape seed extract and propyl gallate,
were able to reduce oxidation in cooked, frozen, reheated ground
beef patties.[32] Furthermore, a number of food-derived antioxida-
tive phenolic compounds among which theaflavin 3,39-digallate,
epicatechin gallate, rosmarinic acid, and naringenin reduced for-
mation of HCAs in beef patties.[33]
Therefore, the aim of the present study is to evaluate the effect
of consumption of processed redmeat products with reduced lev-
els of nitrite and enriched with phytochemicals on the exposure
toNOC and on several biomarkers of effect in a human dietary in-
tervention study. We hypothesize that consumption of processed
red meat products with reduced-nitrite levels and added phyto-
chemicals decreases the exposure to NOC and the associated in-
duction of DNA damage in the large intestine of healthy volun-
teers. Before and after the dietary intervention, gene expression
changes may reflect the molecular responses that are involved in
cancer preventive action of the added phytochemicals or reduced
exposure to NOC. As it is known that nitrate in drinking water
may be converted by oral bacteria into nitrite and thus contribute
to the formation of NOCs in the large intestine, particularly when
high drinking water nitrate is combined with high intake of red
and processed meat,[34–36] this study also aims to quantify the ef-
fect of drinking water nitrate on NOC formation in healthy sub-




Participants were recruited using advertisements in local news-
papers, by social media, and by means of flyers posted at public
locations. Volunteers met with the principal investigator at
Maastricht University, were provided an information brochure,
and were given 1 week to decide whether to participate in the
study. Healthy subjects of both sexes were selected based on
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Table 1. PHYTOME meat product formulations: level of nitrite and nitrate (mg kg−1) and natural extracts (g kg−1) added during meat manufacturing.






Standard-nitrite and reduced-nitrite PHYTOME meat
Polygonum Rutin/Sophora Green tea Origanox White grape Rose-mary Acerola
Cooked ham 100/0 25/0 0.1 0 0 0 0 0 2.5
Raw ham 150/150 75/0 0.3 0 1.5 0.75 0.75 0.3 2.2
Cooked sausage 150/0 25/0 0.1 0.5 1.2 0.65 0.65 0.65 2.5
Dry sausage 150/150 25/0 0.05 0.25 0.65 0.65 0.65 0.65 2.5
Dry cured ham 150/150 0/0 0.08 0.4 1.25 1.25 1.25 1.25 1.25
Dry sausage Southern style 80/150 0/0 0.05 0.25 0.65 0.65 0.65 0.65 2.5
a)
Botanic source or trade name, main bioactive molecules composition %, supplier: Polygonum Cuspidatum root, Resveratrol 98%, Nutraceutica, Italy; Sophora Japonica, Rutin
98%, Indena, Italy; Green tea, Epigallocathechingallate (EGCG) 40%, Indena, Italy; Origanox WS-T, Polyphenols 30% as gallic acid from oregano, sage, Melissa, Frutarom,
Italy; White grape NutriPhy, Polyphenols 95% as gallic acid, Chr Hansen, Italy; Rosemary – Aquarox Polyphenols 15% as gallic acid,Vitiva, Slovenia; Acerola, ascorbic acid
17%, Raps, Germany.
predefined inclusion criteria and randomly and blindly assigned
to one of the different experimental groups. The randomization
procedure was as follows: subjects received a subject number
given in sequence based on the date of signing the informed
consent. Next, subjects were divided based on study start rotating
between group 1 and 2. The participant flowchart is visualized
in Figure S1, Supporting Information. Both healthy men and
women with a body mass index between 18 and 25, in the age
of 18 to 70 years were included in the study. Exclusion criteria
included alcohol abuse up to 6 months before participation in
this research, presence or symptoms of any diseases related
to the gastrointestinal tract, kidney, liver, heart, lungs; the en-
docrine or metabolic system; presence of anemia, HIV infection
or hepatitis; use of antibiotics and other medication over the
last 3 months; smoking, adhering to a vegetarian or vegan diet,
pregnancy, and participating in other intervention studies during
this intervention period. The protocol of the study was in accor-
dance with the guiding principles of the Declaration of Helsinki,
approved by the local Medical Ethics Review Committee of the
Maastricht University Medical Centre+ (registration number:
NL43956.068.13), and registered at Clinical trials.gov under
identifier: NCT04138654. All subjects gave written informed
consent.
2.2. PHYTOME Meat Products
PHYTOME meat products, including cooked sausages, raw and
cooked ham, dry fermented sausages, and dry cured ham, have
been prepared for the human dietary intervention study at two
levels of nitrite: standard-nitrite (group 1) and reduced-nitrite
(group 2) levels. In group 1, preservatives were added accord-
ing to standard manufacturing practices and European rules,[37]
while in group 2, nitrite reduction or elimination was obtained in
safety conditions and preserving the traditional sensory traits of
the end product. Both groups were enriched with selected com-
binations of natural antioxidants and bioactive molecules deliv-
ered by plant extracts. These were carefully selected based on a
number of criteria, that is, the level of scientific evidence for their
antioxidant and/or chemopreventive, and antimicrobial proper-
ties; some basic requirements for these candidate extracts such
as natural origin of all extracts, their commercial availability, and
compatibility with technological requisites. Next, extracts were
tested in several combinations, according to good manufactur-
ing processes, in different trial versions of the innovative meat
products. Furthermore, the extracts should not negatively affect
quality and/or sensory traits of the meat. Commercial extracts
from Poligonum cuspidatum, Sophora japonica, green tea, white
grape, rosemary, oregano, sage, Melissa, and acerola were added
in meat mince or curing brines, as natural sources of polyphe-
nols and ascorbic acid. Depending on the meat item, manufac-
turing techniques were adapted to add the natural extracts to pro-
cessed meats in order to provide a polyphenol intake per serving
that is reported to reduce cancer risk.[38,39] At the same time, ob-
tained PHYTOME meat products showed no or limited impact
on overall sensory acceptability.[40] An overview of the formula-
tion of PHYTOME meat products is provided in Table 1. As re-
ported in Saccani et al.,[40] final meat products show different
concentrations of polyphenols and ascorbic acid, due to a com-
bined effect of the different processing techniques, the added ex-
tracts, and the level of added nitrite. Meat processing techniques
were modified to optimize the final concentrations of bioactive
compounds and to guarantee the quality and sensory traits of
the meat product. In dry and cooked sausages concentrations
around 2–2.5 (as g kg−1 gallic acid equivalents), and 0.5 g kg−1,
respectively, were detected. In the case of dry cured hams, salted
by means of brine vacuum impregnation (BVI)[41] polyphenols
and ascorbic acid concentrations around 1–1.5 and 0.4 g kg−1,
respectively were obtained. Lower amounts of polyphenols and
ascorbic acid were found in cooked and raw hams processed by
brine injection (<0.5 and <0.1 g kg−1, respectively). Processing
techniques have been furtherly revised to ensure safety of meats
processed without nitrite or with added nitrite <50 mg kg−1.[42]
In the case of dry sausage (25 mg kg−1 added nitrite), dry sausage
southern style and dry cured ham (both without added nitrite),
an early cold drying treatment (0–3 °C) has been applied, to al-
low aw reduction and pH decrease (in dry sausages) in safety
conditions.[43,44]
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Figure 1. PHYTOME study design. A = processed red meat products, O = control period with only white meat; B: processed red meat products with
added natural extracts; C = drinking water nitrate at acceptable daily intake (3.7 mg kg−1 body weight) combined with one of the three meat types; X =
sampling moment at time point 1 to 5 (T1–T5). Group 1: standard-nitrite in period B1 (standard-nitrite PHYTOME meat); group 2: reduced-nitrite in
period B2 (reduced-nitrite PHYTOME meat). Period A, B, and O lasted 14 days and period C lasted 7 days.
2.3. Study Design
The human dietary intervention study has a parallel design as
shown in Figure 1. There are two study groups (1 and 2), and
in each study group there are two meat intervention periods (A
and B), separated by a wash-out period (O). During intervention
period “A,” participants were asked to consume the provided
processed red meat products (processed red meat group), while
in period “B” processed red meat products enriched with natural
extracts were provided. For study group 1, the meat products of
both period ”A” and “B” had standard-nitrite levels (standard-
nitrite PHYTOMEmeat), while in study group 2 the nitrite levels
in period “B” were reduced (reduced-nitrite PHYTOME meat).
During period “C” drinking water nitrate was increased to the
Acceptable Daily Intake level (ADI: 3.7 mg kg−1 bodyweight).
Therefore, participants received bottled drinking water each
day, which was individually adjusted to the nitrate ADI level by
adding appropriate amount of KNO3 and adjusting for the reg-
ular daily nitrate intake from other dietary sources. Throughout
intervention periods “A,” “O,” and “B,” all participants received
bottled drinking water with low nitrate levels (<2 mg L−1).
Results from previous intervention studies on NOC formation
indicate that a period of 15 days for each part of the study would
be sufficient to detect changes in the markers to be measured.[45]
Gene expression changes, however, are expected to be observed
earlier.[19] Due to the rapid mitotic activity of the regenerative
cells, the epithelial lining of the crypts and the mucosal surface
of the colon is replaced every 6 to 7 days. Therefore, the wash-out
period of 14 days was considered to be sufficient to remove or
reduce possible effects of the red meat intake to a base level.
An individual food package for each volunteer was compiled
in consultation with a dietitian. These food packages were com-
posed to contain all daily nutritional requirements. The results of
the national food consumption survey in the Netherlands shows
an average daily meat consumption of 150 g per day on average.
In order to maximize intake, it was decided for intake of maximal
300 g of meat per day for a person with a body weight of 80 kg
(3.75 g kg−1 body weight, with a maximum of 300 g per day),
based on previous studies.[19,45] This amount is within the range
of daily meat consumption in the Netherlands, and halfway be-
tween median daily intake and the 95th percentile according to
the RIVM food consumption survey from 2012 to 2014 for the age
group of 21–50 years.[46] During the intervention period, intake
of fruits and vegetables were kept at a low, but acceptable level of
50 g of vegetables and one piece of fruit per day. The food package
for the processed red meat group (“A” period) contained a vari-
ety of cooked and dry-cured red meat products (cooked ham, raw
ham, cooked sausage, dry sausage, and dry cured ham), which
are conventional processed meats, containing standard levels of
nitrite. The food package for the PHYTOME meat (“B” period)
also contained a variety of cooked and dry-cured conventional
red meat products, containing standard levels of nitrite (group
1; standard-nitrite PHYTOME meat) or reduced levels of nitrite
(group 2; reduced-nitrite PHYTOME meat), but with the enrich-
ment of natural extracts. This enriched meat was tested to meet
all quality standards for conventionalmeat products. An overview
of the composition of the PHYTOME meat products is provided
in Table 1. The food package for the “O” period (white meat
group) contained unprocessed chicken and turkey. Fish was ex-
cluded during the entire experimental period in view of the pres-
ence of high amounts of amines which could interfere with the
analyses.[11]
At the beginning of the study and after each intervention pe-
riod of 2 weeks, colonic biopsies were collected during an en-
doscopic examination. First, a rectal swab was taken and sub-
sequently six small colonic biopsies were collected, transferred
to an Eppendorf container and immediately stored in liquid ni-
trogen. Urine was collected during 24 h prior to the endoscopic
examination, in a 2 L bottle. Total sample was weighted, mixed
and 2 × 10 mL was stored at −80 °C until use. One faecal sam-
ple was collected 24 h prior to endoscopic examination. Total
amount was weighted and a small volume was scooped out and
stored at −20 °C until further analysis. About 2–5 mL of saliva
sample was collected in the morning before the endoscopic ex-
amination, and stored at –20 °C until use. Blood samples were
collected before endoscopy using EDTA tubes by means of a
venipuncture. One tube was split over six Eppendorf contain-
ers with RNAlater (Qiagen, Venlo, the Netherland) (0.5 mL blood
with 1.3mLRNAlater) and stored at –80 °C until use. Faecal water,
blood, and colonic biopsies were analyzed for different markers
of exposure and effect. Saliva and faeces, and urine were used
for analyses of the microbiome and nitrate levels, respectively,
the results of which are described in a separate paper.[47] Fur-
thermore, all participants were asked to keep a food diary dur-
ing the whole 7 weeks of intervention to keep track of everything
they consumed (amounts per food product per meal). Partici-
pants were instructed to record their daily dietary intake during
the study using an online standardized food diary from ‘‘Voed-
ingscentrum (https://mijn.voedingscentrum.nl) using the soft-
ware program “Eetmeter” designed by the Netherlands Nutrition
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Centre. For each food item, the amount consumed (standard por-
tions: number of units, glasses, cups) was recorded per day. Food
diaries were processed to calculate the average daily amounts of
energy and nutrients using the “Eetmeter” database.
Nitrate in drinking water may be more important in NOC
formation than nitrate intake through dietary consumption.[34–36]
Therefore, we quantified the effect of drinking water nitrate on
the formation of NOC in healthy volunteers on a high meat
diet. During the first 6 weeks, participants were asked to con-
sume bottled drinking water, which contained low nitrate levels
(< 2 mg L−1). To establish the impact of nitrate in drinking water
on the endogenous nitrosation, we included an extra intervention
period of 7 days in which participants were asked to consume
drinking water with high nitrate levels (“C” period) according
to the ADI level (ADI: 3.7 mg kg−1 bodyweight) in combination
with 300 g (again adjusted for bodyweight) processed red meat,
white meat, or red meat with reduced-nitrite and added natural
extracts, randomly divided over all participants. They received
bottled drinking water that was individually adjusted by addition
of KNO3. Also after this intervention period, participants were
asked again to collect a saliva sample, 24 h urine, and a faeces
sample. The guidelines for nitrate and nitrite levels in drinking
water and meat products were taken into account.
2.4. Faecal Water Apparent Total N-nitroso Compound (ATNC)
Determination
Faecal water was prepared after manual homogenization of the
faecal material for 2 min. by ultracentrifugation at 50,000g ×g
for 2 h at 10 °C. The faecal water supernatant was aliquoted and
stored at –20 °C until use.[48] The faecal level of NOC is fre-
quentlymeasured as Apparent Total Nitroso Compounds (ATNC)
and used as indicator of colonic endogenous nitrosation.[9]
ATNC concentrations were determined using chemical denitro-
sation with chemiluminescence detection and quantified using
a NaNO2 standard curve, on a Ecomedics CLD-88 with custom-
made glassware, as described van Breda et al.[36] In short, faecal
water samples were thawed on ice in the dark to prevent UV-
induced denitrosation. 50 μL of faecal water was treated briefly
(1 min) with preservation solution (0.1 M N-ethylmaleimide and
0.01 M DTPA) then incubated with 50 g L−1 sulfamic acid for
4 min. The sample was directly injected to the purge vessel (60
°C) containing 10–15 mL reduction solution (11.11 g L−1 potas-
sium iodide and 5.55 g L−1 iodine in 40 mL water and 140 mL
glacial acetic acid). Results are expressed as μmol ATNC per L
faecal water.
NOCs were measured as apparent total N-nitroso compounds
(ATNC). ATNC concentrations were determined using a chemi-
luminescence detector (CLD).[28] Thawed faecal water samples
were kept in the dark on ice and analyzed as soon as possible
and within 2 h. 100 μL of faecal water sample was treated briefly
with preservation solution (0.1MN-ethylmaleimide and 0.01M
DTPA) and then incubated with 50 g L−1 sulfamic acid for 1–
5min. Nitrite content forms a diazo complex with the sulfamic
acid that is stable in tri-iodide, this step is necessary to differ-
entiate the nitrite content from the ATNC content. The sample
was directly injected to the purge vessel (60 °C) containing 10–
15mL reduction solution (11.11 g L−1 potassium iodide and 5.55
g L−1 iodine in 40 mL water and 140 mL glacial acetic acid).
Preservation solution was added to preserve the nitrosation state
of thiols by alkylating free thiol groups and scavenging metal
ions, which can cause a release of NO from nitroso-thiols. Tri-
iodide reduction solution releases NO from nitrite, nitrosothiols,
nitrosamines, iron-nitrosylhemoglobin, and nitrosohemoglobin.
ATNC contribution to the total CLD signal was determined by
subtracting the nitrite response from the total response. All sam-
ples and standards were measured in duplicates.
2.5. Analysis of Faecal Water Genotoxicity
The human colon adenocarcinoma cell line Caco-2 was used to
test fecal water genotoxicity in the comet assay.[19] Caco-2 cells
(passages 33–38) were maintained in DMEM (Sigma-Aldrich,
D5796), supplemented with 1% penicillin/streptomycin (Gibco,
15070-063), 1% MEM NEA (Gibco, 11140-035), 1% sodium
pyruvate (Gibco, 11360-039), and 10% FBS. Cells were harvested
using 0.05% Trypsin-EDTA (Gibco, 25300-054). Cell cultures
were incubated at 37 °C in a humidified incubator containing
5% CO2. For exposure to faecal water, cells were harvested by
trypsinization and resuspended in growth medium containing
10% faecal water to a final concentration of 2 × 106 cells mL−1,
mixed with 50 μL faecal water, and incubated at 37 °C for
30 min. The comet assay was subsequently performed in trip-
licate as described by Singh et al.[49] and Pflaum et al.[50] with
minor modifications. Comets were visualized using a Zeiss
Axioskop fluorescence microscope (at 200x magnification). Ran-
domly, 50 cells were analyzed using the Comet assay III software
(Perceptive Instruments, Haverhill, UK). DNA damage was
expressed as tail moment (TM, the product of tail DNA content
and mean tail migration distance). From each sample an A and
B slide were made which were electrophoresed on the same day
in a different run. Also included during each electrophoresis run
were a positive (i.e., Caco-2 cells treated with 200 μMH2O2) and
negative (i.e., Caco-2 cells treated with DMEM) control sample
in order to compensate for any inter-electrophoresis variation.
2.6. DNA Adducts Analyses in Colonic Biopsies
2.6.1. DNA Isolation
Colonic biopsies were disrupted using a tissue homogenizer, sub-
sequently lysed in 500 μL digestion buffer (containing 0.5 M
EDTA; 1 M Tris–HCl, pH 8.0; 10% SDS) and incubated for 1 h at
55 °C. Next, 25 μL of proteinase K (20 mg mL−1) (Ambion) was
added. After incubation during 1 h at 55 °C, the proteinase K was
inactivated for 10 min at 80 °C. RNAse A (2 μL; 100 mg mL−1)
(Qiagen) and collagenase (25 μL; 1%) (Sigma) treatment was per-
formed for 1 h at 37 °C. Thereupon, 500 μL of phenol-chloroform-
isoamylalcohol (PCI; 25:24:1) (Sigma) was added. The mixture
was shaken manually for 5 min, and centrifuged for 5 min at
maximum speed. The upper phase was transferred to a new Ep-
pendorf tube and the PCI step was repeated. The upper phase
was collected and precipitated using 50 μL 3 M NaAc pH 5.6
and 1250 μL cold 100% ethanol for 30 min at –80 °C. After cen-
trifugation for 30 min at maximum speed, the DNA pellet was
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washed using cold 70% ETOH, dried in a speed vac and dis-
solved in 100 μL nuclease free water. The total amount was at
least 30 μg DNA, the 260/280 ratio ranged between 1.7 and 1.9,
and the 260/230 ratio between 2.2 and 2.3.
2.6.2. Analysis of O6-methylguanine Adducts
Exposure to certain NOCs causes O6-methylguanine (O6-MeG)
adducts formation. O6-MeG DNA adducts are also mutagenic
and have frequently been shown to occur in human CRC
tissue.[51,52] Samples were analyzed using an ELISA method de-
scribed by Georgiadis et al.[53] In short, restriction enzymes were
used to digest DNA to fragments of size expected to contain
no more than one O6-meG residue. Anti-adduct antisera were
used to transfer O6-meG–containing fragments to a solid surface,
where they were detected using anti-ssDNA antisera. A chemilu-
minescence signal was finally generated by the addition of CDP-
Star substrate containing Emerald II enhancer. Chemilumines-
cence was measured using a Safire II Microplate Luminometer
(TECAN) at 542 nm. For the quantitation of O6-meG in unknown
DNA samples, a standard curve consisting of DNA standards
containing different levels of O6-meG were prepared with DNA
fromHeLa cells. The assay has a limit of detection of 1.5 adducts
per 109 nucleotides using 10 μg of DNA.
2.7. Transcriptomics Analyses of Colonic Tissue
2.7.1. Total RNA Isolation
Colon biopsies were dissolved in QIAzol (Qiagen, Venlo, The
Netherlands) using a tissue disruptor. RNA was isolated accord-
ing to the manufacturer’s protocol l and followed by DNase I (Qi-
agen) treatment. Upon purification, RNA concentrations were
measured by means of a NanoDrop ND-1000 spectrophotome-
ter (Thermo Scientific) at 260 and 280 nm. RNA quality and in-
tegrity were assessed by using automated gel electrophoresis on
an Agilent 2100 Bioanalyzer system (Agilent Technologies) (av-
erage RNA integrity number: 7.1 ± 1.0). For one subject, RNA
isolated at time point one was of insufficient quality and there-
fore not included in subsequent analyses.
2.7.2. Gene Expression Microarrays
Microarray hybridization was performed on Agilent 8 ×
44K whole human genome microarrays as described previously
with some modifications.[17,18] Quality control check was done in
R (www.r-project.org) using Bioconductor, including local back-
ground correction, flagging of bad spots, controls and spots with
too low intensity, log2 transformation and normalization. Data
were normalized per batch (date of microarray hybridization) us-
ing quantile normalization. Two arrays were excluded due to bad
quality. In total, data of 247 arrays were included in the analy-
ses. Genes with less than 30% flagged bad spots were used as a
pre-processed input file. Replicates were merged using the me-
dian and missing values were imputed by k-nearest neighbours
(KNN) imputation (N = 15). In order to check for multicollinear-
ity, a Variance Inflation Factor test for gender, age, BMI, phy-
tochemicals, subject, levels of ATCN, grams of meat and batch
effect using the R package HH (http://cran.r-project.org/web/
packages/HH/index.html) was carried out. Variables that do not
present multicollinearity can be analyzed independently. The val-
ues were all below 4, indicating absence of multicollinearity be-
tween the variables of study. Next, hierarchical clustering on all
probes (16,734) was carried out to identify potential outliers in
each group. From 59 individuals, four were removed from the
processed redmeat group, and two were removed from the white
meat group and PHYTOME meat group (Figure S1, Supporting
Information).
The microarray data have been deposited in NCBI’s Gene Ex-
pression Omnibus[54] and are accessible through GEO series
accession number GSE 147996 https://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc = GSE147996).
2.7.3. Selection of Differentially Expressed Genes Using LIMMA
Analysis
A list of differentially expressed genes (DEGs) for each group
compared to the other groups was generated using the Linear
Model for Microarray Analysis (LIMMA) analysis from Biocon-
ductor (https://bioconductor.org/biocLite.R) (absolute FC > 1.2;
FDR corrected p-values < 0.05 [FWER-corrected using the False
Discovery Rate]), correcting for sex, age, BMI, and batch of mi-
croarray hybridization between the different groups.[55] LIMMA
makes use of linear models to assess differential expression in
the context of multifactor designed experiments. It provides the
ability to analyze comparisons betweenmany RNA targets simul-
taneously.
2.7.4. Selection of Genes Associated with Exposure Using Linear
Mixed Model Analysis
A linear mixed model analysis was carried out in order to gen-
erate lists of significant genes associated with different condi-
tions using the lme4 R package (https://cran.r-project.org/web/
packages/lme4/index.html). This approach has been success-
fully used in previous studies.[56,57] In short, for each subject i, we
performed the mixed model Yi∼𝛼+𝛽1Xi+𝛽2FEi+uAi+∈i, where
Xi is the variable of interest, Yi are the predictors (gene expres-
sion), FEi are the fixed effects (confounders), Ai represents the
value of the random effect, 𝛼 is the intercept, 𝛽1/𝛽2 are the re-
gression coefficients for each variable and ∈i is the residual or
difference between observed values and calculated ones by the
model. We applied three different linear mixed model analyses.
The first one studies the effect of ATCN levels on gene expression
correcting for the confounders age, gender, BMI and yes/no phy-
tochemicals and the random effects subject, batch of RNA isola-
tion, samples labeling, andmicroarray hybridization. The second
model was applied to study the effect of introducing phytochem-
icals on gene expression. The model remains the same as the
first one but correcting for ATCN levels as confounder instead of
yes/no phytochemicals. The last model was implemented to an-
alyze the effect of the interaction ATCN and yes/no phytochemi-
cals, keeping the same confounders as before and correcting for
the individual variables of ATCN and yes/no phytochemicals.
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2.7.5. Data Analyses: Pathway Analyses and Network Visualization
of Significant Genes
Gene lists were uploaded onto the web-tool ConsensuspathDB[58]
in order to identify the biological pathways that were over-
represented (FDR corrected p-value < 0.01, >2 genes per
pathway). Next, genes were uploaded onto the induced network
modules application, in order to identify connections between
the genes. Networks consisting of less than five genes were ex-
cluded. Generated networks were exported and visualized using
Cytoscape.[59] Fold changes of DEGs in case of LIMMA analyses
or regression coefficients in case of LMM were imported and
visualized on the network nodes. A selection of genes which
showed a high number of interactions with other genes were
explored in more detail, and their role in development of CRC
was investigated.
2.8. Statistical Analyses
Statistical analyses were performed using IBM Statistics SPSS,
version 24 (IBM, Amsterdam, the Netherlands). Normality of the
data was checked by means of histograms and Q-Q plots. Sig-
nificant differences in age, BMI, meat intake, and physical ac-
tivity between group 1 and 2 were analyzed using Student’s t-
test. Homogeneity of variance was tested by Levene’s test. All
tests were two-sided and a p-value <0.05 was considered sta-
tistically significant. Significant differences between the differ-
ent time points for intake of energy and dietary macronutrients,
ATNC, O6-methylguanine adducts, mean and median TM, were
assessed by means of repeated measures ANOVA. In case of a
significant finding (p-value <0.05), between group analyses were
performed by means of pairwise t-tests. All tests were two-sided
and a p-value <0.05 was considered statistically significant. Data
are presented as the mean (SD), unless otherwise stated.
3. Results
3.1. Study Population
In total, 78 participants were recruited and included in the study.
As a consequence of 15 drop-outs, mostly due to illnesses pre-
ceeding the study start, 63 participants started the full study.
Characteristics of the study population are presented in Table 2.
Male and female participants were equally distributed over group
1 and 2, with respectively standard or reduced-nitrite levels in
the processed red meat products and enriched for phytochem-
icals. Age, BMI, meat consumption, and physical activity were
not significantly different between the two groups. Furthermore,
no significant differences in intake of energy during the differ-
ent intervention periods were observed (Table S1, Supporting In-
formation). However, daily intake of total fats and saturated fats
were significantly lower (p < 0.001) and intake of carbohydrates
and proteins were significantly higher (p < 0.05, and p < 0.001,
respectively) during the control period in which white meat was
consumed, as compared to the intake of these macronutrients
during the other intervention periods. This can be attributed to
the difference in consumed meat type, as white meat contains
relatively more proteins and less total and saturated fats.










Participants [n] 63 31 32
Females [n] 32 16 16
Males [n] 31 15 16
Age [years] 25.4 (8.5) 25.9 (9.3) 24.6 (7.6)
BMI [kg m−2] 22.3 (2.1) 22.0 (2.1) 22.6 (2.1)
Meat intake [g per day] 254 (38) 248 (38) 259 (37)
Physical activity [h per week] 6.5 (3.8) 7.1 (4.2) 5.9 (3.3)
a)
No statistically significant differences between group 1 and 2.
3.2. Apparent Total N-nitroso Compound Exposure
ATNC levels were measured in faecal waters and data for the
complete intervention study (all time points) were available for
52 subjects (Table 3). ATNC levels were significantly different be-
tween the groups (repeated measures ANOVA, p < 0.05). Using
paired t-tests, no statistically significant differences were found
between baseline ATNC and ATNC after the different meat in-
terventions. However, ATNC levels were significantly higher fol-
lowing processed red meat intake when compared to white meat
intake (p < 0.05), standard-nitrite PHYTOME meat intake (p
< 0.05), and intake of PHYTOME meat with reduced levels of
nitrite (p < 0.001). Furthermore, intake of white meat resulted
in significantly higher levels of ATNC as compared to consump-
tion of PHYTOME meat with reduced levels of nitrite (p < 0.05)
(Figure 2A).
ATNC levels after combined intake of the different meat types
and drinking water nitrate levels at the ADI levels are displayed
in Figure 2B. The consumption of processed red meat in com-
bination with drinking water with high nitrate levels resulted in
higher ATNC levels as compared to consumption of white meat
(p < 0.05) combined with drinking water containing low nitrate
levels and as compared to consumption of PHYTOMEmeat with
reduced levels of nitrite combined with drinking water with high
nitrate levels (p< 0.01). No significant differences were found be-
tween ATNC levels after white meat intake in combination with
low nitrate levels in drinkingwater and after intake of PHYTOME
meat combined with high levels of nitrate in drinking water.
In order to establish differences in ATNC excretion between
high and low drinking water nitrate for each period of meat prod-
ucts separately, we have calculated the ATNC ratio for each partic-
ipant for consumption of high and low levels of nitrate in drink-
ing water. The ratio was significantly higher than 1 (single-sided
t-test, p < 0.05) for all interventions except for the processed red
meat. The mean ratios were 1.9 (95% CI: 1.1–2.6) for PHYTOME
meat with standard-nitrite levels, 2.6 (95% CI 1.1–4.2) for PHY-
TOMEmeat with reduced-nitrite levels, and 2.3 (95% CI 1.3–3.3)
for white meat. For processed red meat, the mean ratio was 1.9
(95% CI: 0.9–2.8), but this was not statistically significant. These
results show that nitrate at the ADI level in drinking water stim-
ulates the formation of NOCs.
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Table 3. Fecal water apparent total N-nitroso compounds (ATNC) levels, DNA strand breaks, and DNA adduct levels (O6-methylguanine [O6-MeG]: only
for subjects with standard levels of nitrate in drinking water) of subjects consuming different meat products for 2 weeks in combination with a normal
or high (acceptable daily intake [ADI] level of 3.7 mg kg−1 body weight) nitrate levels in drinking water (mean [SD]); for DNA strand breaks: first line
value represents mean (SD), second line value represents median (SD).
Drinking water
nitrate levels








Normal (low) ATNC [μmol L−1]
a)




10.8 (11.8) 7.4 (4.8)

















2.6 (0.9) 1.4 (0.7)
h)
2.4 (0.4) 2.6 (0.9)
High (ADI level) ATNC [μmol L−1] N.A. 21.0 (12.8)
i)
17.6 (12.1) 17.8 (24.1) 10.3 (7.9)









Significantly different between the groups (repeated measures ANOVA, p < 0.05);
b)
Significantly higher as compared to white meat group (pairwise t-test, p < 0.05),
PHYTOME meat group standard-nitrite (pairwise t-test, p < 0.05), and PHYTOME meat group reduced-nitrite (pairwise t-test, p < 0.001);
c)
Significantly higher as compared
to PHYTOME meat group reduced-nitrite (pairwise t-test, p < 0.05);
d)
Significantly different between the groups (repeated measures ANOVA, p < 0.05 [for mean TM]);
e)
Significantly lower as compared to baseline (pairwise t-test, p < 0.01), and after 2 weeks of processed red meat consumption (pairwise t-test, p < 0.01);
f)
Significantly
different between the groups (repeated measures ANOVA, p < 0.001);
g)
Significantly lower as compared to processed red meat group (pairwise t-test, p < 0.01), and as
compared to PHYTOME meat group reduced-nitrite (pairwise t-test, p < 0.001);
h)
Significantly lower as compared to baseline (pairwise t-test, p < 0.01), as compared to
processed red meat group (pairwise t-test, p < 0.001), as compared to PHYTOME meat standard-nitrite group (pairwise t-test, p < 0.001), and as compared to PHYTOME
meat group reduced-nitrite (pairwise t-test, p < 0.001);
i)
Significantly higher as compared to white meat group combined with drinking water containing low nitrate levels
(Student’s t-test, p < 0.05), and PHYTOME meat group reduced-nitrite combined with drinking water containing high nitrate levels (Student’s t-test, p < 0.05).
3.3. Genotoxicity of Faecal Water
A significant difference was observed between the different
intervention groups (repeated measures ANOVA, p < 0.05). The
highest level of genotoxicity in Caco-2 cells exposed to faecal
water is found at the start of the study (baseline) (Table 3). At
baseline and after 2 weeks of consumption of the processed red
meat products (processed redmeat group), the capacity to induce
DNA strand breaks was significantly higher as compared to the
faecal genotoxicity in the control period when only white meat
was consumed (p < 0.01). No statistically significant differences
were observed between the genotoxicity of faecal water after
consumption of meat containing the added phytochemicals
(standard-nitrite PHYTOME meat and reduced-nitrite PHY-
TOME meat) as compared to consumption of white meat. No
additional effect of different nitrate levels in drinking water on
genotoxicity was observed.
3.4. DNA Adduct Levels in Colonic Tissue
3.4.1. O6-MeG DNA Adduct Levels
The levels of O6-MeG DNA adduct in colonic tissue were signif-
icantly different between the different interventions (repeated
measures ANOVA, p < 0.001) (Table 3). At baseline, O6-MeG
DNA adduct levels in colonic tissue were significantly lower
as compared to the levels after 2 weeks of consumption of the
processed red meat products (p < 0.01), and as compared to
PHYTOMEmeat products with reduced nitrite levels (p< 0.001).
The O6-MeG DNA adduct in colonic tissue were lowest after 2
weeks of white meat consumption (white vs baseline: p < 0.001;
white vs processed red meat: p < 0.001; white vs PHYTOME
meat standard-nitrite: p < 0.001; white vs PHYTOME meat
reduced-nitrite p < 0.001).
3.5. Gene Expression Analyses
3.5.1. Differentially Expressed Genes after Consumption of Different
Meat Products
Differentially expressed genes (DEGs) after consumption of dif-
ferent meat types were identified by LIMMA analysis. DEGs
were identified as compared to baseline levels for the processed
red meat group, that is, 12 genes, counting 7 up- and 5 down-
regulated genes; for the PHYTOME meat group, that is, 170
DEGs, including 61 up- and 109 downregulated genes; and, for
the standard-nitrite PHTYTOMEmeat group, including only one
downregulated gene. Detailed information on the DEGs is pro-
vided in Tables S2A–C, Supporting Information.
As the number of DEGs identified for the processed red
meat group and the standard-nitrite PHYTOME meat group
are low, no pathway analyses were performed, but instead the
function of all DEGs and their relation to CRC development
and/or phytochemicals were explored using the NCBI portal
(https://www.ncbi.nlm.nih.gov/gene) and a literature review, re-
spectively (overview provided in Table S3A,B, Supporting Infor-
mation). Four genes which were modulated in the processed
red meat group, that is, gremlin 2, DAN family BMP antago-
nist (GREM2), carbonic anhydrase VII (CA7), aldo-keto reductase
family 1, member B10 (aldose reductase) (AKR1B10), and RAS
protein activator like 1 (GAP1 like) (RASAL1) are reported to play
a role in the colon and/or CRC and will be further described in
the discussion.
Overrepresentation analyses of the 170 DEGs found for the
PHYTOME meat group as compared to baseline, identified 63
significantly modulated biological processes which are mostly
related to cell cycle, the complement and coagulation system, and
cholesterol biosynthesis (Table S3C, Supporting Information).
Differentially expressed genes were used as input for creating
a network which identified the known biological interactions
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Figure 2. Apparent total N-nitroso compound (ATNC) levels in faecal wa-
ter (μmol L−1) (median, interquartile range, and range—excluding out-
liers) in human subjects after an intervention with daily consumption of
300 g (adjusted for bodyweight with a maximum of 300 g for a person of
80 kg) of different meat products for 2 weeks (white meat, processed red
meat, processed red meat with a standard level of nitrite and added phyto-
chemicals [standard-nitrite PHYTOME meat], or processed red meat with
a reduced level of nitrite and added phytochemicals [reduced-nitrite PHY-
TOMEmeat]). A) In combination with low drinking water nitrate levels. *p
< 0.05; ***p < 0.001: ATNC levels after processed red meat intake signifi-
cantly higher as compared to intake of white meat (p < 0.05), after intake
of PHYTOME meat with standard levels of nitrite (p < 0.05), and after in-
take of PHYTOME meat with reduced levels of nitrite (p < 0.001). ATNC
levels after white meat intake significantly higher as compared to levels
after intake of PHYTOME meat with reduced-nitrite levels (p < 0.05); B)
In combination with drinking water nitrate levels at the acceptable daily
intake level of 3.7 mg kg−1 body weight. *p < 0.05; ** p < 0.01: ATNC
levels after intake of processed red meat combined with drinking water
containing high levels of nitrate significantly higher as compared to ATNC
levels after white meat consumption combined with drinking water con-
taining low nitrate levels (p < 0.05), and significantly higher as compared
to intake of PHYTOME meat with reduced-nitrite levels combined with
drinking water containing high nitrate levels (p < 0.05).
between these DEGs. One large network consisting of 15 genes
and one small network consisting of five genes was generated
(Figure 3A,B, Tables S3D,E, Supporting Information). Central
in the large network, the cyclin-dependent kinase 1 (CDK1)
gene was connected to nine other genes, including cyclin B1
(CCNB1), PDZ binding kinase (PBK), cyclin-dependent kinase
inhibitor 2C (CDKN2C), kinesin family member 4A (KIF4A),
cyclin-dependent kinase inhibitor 3 (CDKN3), topoisomerase
(DNA) II alpha (TOP2A), SET domain containing (lysine
methyltransferase) 7 (SETD7), TPX2, microtubule-associated
(TPX2), and TTK protein kinase (TTK) (all downregulated).
The small network consisted of one central gene, that is, KIT
proto-oncogene receptor tyrosine kinase (KIT, downregulated),
which was linked to the four other genes, that is, EPH receptor
A4 (EPHA4) and SHC (Src homology 2 domain containing)
transforming protein 2 (SHC2), (upregulated), and MAD2 mi-
totic arrest deficient-like 1 (MAD2L1) and SH2B adaptor protein
3 (SH2B3) (downregulated).
3.5.2. Genes Associated with Different Exposure Conditions
Linear mixed model analyses were carried out in order to gen-
erate lists of significant genes associated with ATNC excretion,
with the presence of phytochemicals, and with the interaction
between the two. At an FDR < 0.05, one model gave significant
results, showing 25 genes which were significantly associated
with ATNC exposure (Table S2D, Supporting Information),
including 13 negatively and 12 positively correlating genes. Two
significantly modulated pathways involving serine and glycine
biosynthesis, each containing two overrepresented genes, that is,
vacuolar protein sorting 29 homolog (Saccharomyces cerevisiae)
(VPS29) and phosphoserine phosphatase (PSPH) (overview pro-
vided in Table S3F, Supporting Information) were identified by
pathway analyses. By using a less strict FDR cut off (FDR< 0.15),
249 significant genes were identified associated with the addition
of phytochemicals to the diet, of which 144 were positively corre-
lated and 105 were negatively correlated (Table S2E, Supporting
Information). Genes are overrepresented in 121 pathways, in-
volving mainly cell cycle and DNA repair related biological pro-
cesses (ConsensuspathDB, FDR < 0.01) (Table S3G, Supporting
Information). A large network could be generated comprising 86
genes demonstrating 186 connections. In addition, two smaller
networks of seven and five genes respectively, were created (Table
S3H,I, Supporting Information, Figure 4A). Seven genes, all neg-
atively correlated, in the large network connected tomore than 10
other genes, that is, cyclin-dependent kinase 2 (CDK2) (38 con-
nections),CDK1 (36 connections), replication protein A1 (RPA1),
BRCA1 associated RING domain 1 (BARD1) (both 15 connec-
tions), protein phosphatase 1, catalytic subunit, gamma isozyme
(PPP1CC) (12 connections), retinoblastoma 1 (RB1), and pro-
liferating cell nuclear antigen (PCNA) (both 11 connections).
Creation of a subnetwork of these seven genes with their in-
teracting genes demonstrated that these seven genes highly
interacted with each other directly, or via an intermediate gene
(Table S3J,K, Supporting Information, Figure 4B). In addition
to the identification of genes significantly associated with the
addition of phytochemicals in the diet, the linear mixed model
analyzing the interaction of ATNC and yes/no phytochemicals
identified 214 significantly associated genes, of which 49 were
negatively and 165 were positively correlated (Table S2F, Sup-
porting Information). These genes are mainly involved in the
biological processes glycolysis and gluconeogenesis, as shown
by pathway analyses (ConsensuspathDB, FDR < 0.01) (Table
S3L, Supporting Information).
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Figure 3. Network presentation of differentially expressed genes (DEGs) in colonic tissue of subjects (n= 57) consuming 2 weeks of processed red meat
enriched with phytochemicals (PHYTOME meat) compared to baseline levels. A) Network of 15 unique DEGs containing 18 biological interactions; B)
Network of five unique DEGs showing four biological interactions (Table S3D,E, Supporting Information). Networks were generated in Cytoscape[59]
based on the outcome of the induced network module application in ConsensupathDB (www.http://consensuspathdb.org/)[58] using 170 unique DEGs
as input list (Table S2B, Supporting Information). Fill color of the nodes represent control-corrected log2 fold changes of DEGs Red: upregulation; Green:
downregulation.
4. Discussion
In the PHYTOME project, we aimed to evaluate the impact of
reformulated processed meat products enriched with natural
bioactive compounds on the exposure levels of potentially car-
cinogenic NOCs in humans. The main finding of this human
dietary intervention study is that consumption of PHYTOME
meat products leads to a significant reduction in fecal ATNC
levels, a surrogate marker of endogenously formed NOCs,[9]
as compared to the consumption of conventional processed
red meat products. This outcome shows that the addition of
natural plant extracts during red meat processing can reduce the
endogenous formation of NOCs, even without the simultaneous
reduction of nitrite added as a preservative, as the only difference
between the conventional meat products and the PHYTOME
meat products with standard nitrite levels are the added phyto-
chemicals. The observed ATNC concentrations in faecal water
are comparable to those found after consumption of white meat.
Addition of natural extracts in combination with reduction of
nitrite lowered the level even further, as compared to the level
of ATNC after consumption of white meat. There is no addi-
tional signficant reduction in ATNC levels in faecal water after
consumption of PHYTOME meat with reduced levels of nitrite
as compared to the level after consumption of PHYTOME meat
with standard levels of nitrite. Notably, the level of significance
is higher in the comparison between processed red meat and
processed red meat with reduced levels of nitrite and added phy-
tochemicals as compared to the comparison between processed
red meat and processed red meat with standard levels of nitrite
and added phytochemicals. This indicates that reduction of
nitrite increases the strength of evidence in probabilistic terms.
As the exposure to NOCs is one of the suggested mechanisms
by which red and processed red meat can increase the risk of
CRC,[3] a reduction in their formation is likely to have a beneficial
effect.
On the other hand, increasing drinking water nitrate to the
level of the ADI is found to stimulate the formation of ATNC,
specifically in combination with conventionally processed red
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Figure 4. Network presentation of significantly associated genes in colonic tissue of subjects (n = 52) with the presence of phytochemicals in the diet.
A) Large network of 86 genes containing 184 interactions, and two small networks of seven and five genes, respectively, showing six and four interactions
(Table S3G–I, Supporting Information); B) Subnetwork of 50 genes containing 104 interactions (Table S3J,K, Supporting Information) extracted from
the large network in (A). The seven genes presented in dashed black circles were connected to more than 10 other genes in the large network, that is,
cyclin-dependent kinase 2 (CDK2) (38 connections), CDK1 (36 connections), replication protein A1 (RPA1), BRCA1 associated RING domain 1 (BARD1)
(both 15 connections), protein phosphatase 1, catalytic subunit, gamma isozyme (PPP1CC) (12 connections), retinoblastoma 1 (RB1), and proliferating
cell nuclear antigen (PCNA) (both 11 connections). Networks were generated in Cytoscape[59] based on the outcome of the induced network module
application in ConsensupathDB (http://www.consensuspathdb.org/)[58] using the 244 significant genes in colonic tissue of subjects associated with the
presence of phytochemicals in the diet. Fill color of the nodes represent log2 regression coefficients. Red: positive regression coefficient; Green: negative
regression coefficient.
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Figure 4. Continued
meat products. ATNC levels also tended to be higher after the
combined intake of drinking water containing nitrate at the ADI
level and white meat. These findings confirm the results of our
pilot study in which we investigated the contribution of nitrate
in drinking water in combination with either consumption
of processed red meat or white meat on endogenous NOC
formation.[36] The combination of reduced-nitrite in the PHY-
TOME meat and low levels of nitrate in drinking water induced
the largest reduction on the endogenous formation of NOCs.
The results from the current study indicates that consumption
of nitrite and nitrate enhances endogenous nitrosation, but that
addition of phytochemicals can significantly inhibit this. These
findings imply that dietary intake of both nitrite and nitrate
from other sources should be taken into consideration when
cancer risk assessments are made for the consumption of meat
products.
By fecal water genotoxicity measurements, it was confirmed
that the consumption of processed red meat products increased
DNA strand breaks in colonic cells as compared to the consump-
tion of whitemeat. These results are in line with those from a pre-
viously conducted human dietary intervention study in which pa-
tients with either inflammatory bowel disease or irritable bowel
syndrome consumed a high red meat diet consisting of 300 g of
red meat per day for 7 days.[19] After the intervention, mean lev-
els of DNA strand breaks induced ex vivo in Caco-2 cells by fecal
water were significantly higher. In the present study, no statisti-
cally significant difference in the level of DNA strand breaks was
found after PHYTOME meat consumption as compared to con-
sumption of white meat or processed red meat, either with or
without nitrite reduction, indicating no difference in genotoxic
potential between PHYTOME meat products and conventional
processed red meat products or white meat.
O6-methylguanine adducts levels in colonic tissue were lowest
after consumption of white meat. The adduct levels were signif-
icantly higher at baseline, after consumption of conventionally
processed red meat products, and after consumption of the
PHYTOMEmeat products, as compared to white meat. Previous
studies have shown that O6-methylguanine adducts are present
in CRC tissue, and several in vitro[60] and animal in vivo[61,62]
studies have demonstrated an increase in the number of adducts
after NOC exposure. This is the first human intervention study
that reports the increase of this adduct in colon tissue after
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an intervention with processed red meat. Although exposure
to ATNC was reduced in the subjects after consumption of
the PHYTOME meat products, this did not result in a lower
O6-methylguanine adduct level in their colon.
Gene expression analyses were carried out in colonic tissue in
order to elucidate the molecular mechanisms that are affected
by the dietary intervention. It was shown that consumption
of processed red meat modulated the expression 12 genes in
colonic tissue of which three are known to be involved in CRC
development, that is, CA7, AKR1B10, and RASAL1, and of which
one plays a role in normal colonic tissue differentiation, that
is, GREM2. The downregulated CA7 gene encodes a metallo-
enzyme which catalyses the conversion of CO2 to the bicarbonate
ion and protons. This reaction is involved in many physiological
and pathological reactions, including tumourigenicity.[63] Clini-
cal studies have shown that CA7 expression is downregulated in
CRC tissue both at the mRNA and protein level. Furthermore,
decreased expression of CA7 correlates with CRC progression
and a poor clinical prognosis.[64] Suggested mechanisms involve
dedifferentiation[64] and reduced protection against oxidative
stress.[65] AKR1B10, which was also downregulated after pro-
cessed red meat consumption in the current study, is specifically
expressed in the small intestine and colon, and identified as a
direct target of p53.[66] It is member of the aldo-keto reductase
superfamily and encodes for an enzyme that catalyses the reduc-
tion of electrophilic carbonyl compounds to less toxic alcoholic
metabolites, thereby protecting the intestinal cell against DNA
damage.[67] Several studies have reported a decreased expression
level of AKR1B10 in colorectal carcinomas.[66,68,69] In particular,
it was lost or decreased in CRC tissue, precancerous tissue,
and even in normal adjacent tissue.[69] Possible mechanisms by
which AKR1B10might contribute to CRC development and poor
clinical prognosis comprise inhibition of p53-induced apoptosis
and loss of proliferative suppression of CRC cells.[66] RASAL1
was upregulated in the colon of subjects consuming processed
redmeat. The protein product of this gene controls cellular prolif-
eration and differentiation by suppressing the normal RAS func-
tion. It was found to be overexpressed in CRC cells with the mu-
tant KRAS variant. Furthermore, it was suggested that RASAL1
functions in the progression of benign colonic neoplasms.[70]
Therefore, in subjects who are at risk for CRC and bear benign
polyps in their intestine containing mutated KRAS genes, up-
regulation of this gene could lead to progression to advanced
malignant lesions. In addition to these three genes of which
is reported that their expression is changed in CRC tissue, the
expression of GREM2 was downregulated. The protein product
of this gene is an antagonist of BMP (bonemorphogenic protein)
signaling, and expression of GREM2 contributes to inhibition
of differentiation of basal crypt epithelial cells.[71] A role of BMP
signaling has been suggested in the inhibition of self-renewal of
intestinal stem cells by inhibition ofWnt signaling.[72] Therefore,
aberrations in the expression of genes involved in BMP signaling
which plays an important role in the correct development of the
colonic crypt are not desired. In conclusion, subjects consuming
processed red meat show colonic gene expressions that are
linked to increased cell proliferation and dedifferentiation.
Subjects consuming processed red meat excreted highest
ATNC levels and linear mixed model analyses identified two
genes associated with ATNC exposure, that is, PSPH (positively
correlated), and VPS29 (negatively correlated), both overrepre-
sented in the serine and glycine biosynthesis pathway. Serine
and glycine (which can be formed out of serine) are important
amino acids with a role in cancer cell metabolism by acting as
precursors for synthesis of proteins, nucleic acids, and lipids
which are important for cancer cell growth.[73] With increas-
ing ATNC exposure, the expression of PSPH also increased,
potentially stimulating serine formation, thereby contributing
to synthesis of building blocks for increasing cell growth. In a
previous human dietary intervention study performed by our
group, in which human healthy volunteers consumed 300 g
red meat per day for 7 days, genes significantly correlating with
the increase in fecal water genotoxicity were involved in similar
biological pathways as found in the current study, including
cell cycle and WNT signaling.[19] This emphasizes the possible
contribution of these processes in red meat induced CRC risk.
Cell proliferation is also the main affected biological process
on gene expression level in colonic tissue of subjects consuming
the PHYTOMEmeat.CDK1 (downregulated), the central gene in
a large network of differentially expressed genes, is a key player in
cell cycle regulation (Figure 3A). It forms a complex with CCNB1
(downregulated), which promotes several events in mitosis. It
is responsible for phosphorylation of PBK (downregulated) dur-
ing mitosis which is required for its mitotic activity.[74] In ad-
dition to its role in cytokinesis during mitosis, overexpressed
PBK is found in numerous cancers such as colorectal cancer,[75]
bladder cancer,[76] and gastric cancer.[77] In addition to CCNB1,
CDK1 is linked to other genes involved in cell cycle regulation
in the network, such as TOP2A, SPC25, NDC80 kinetochore
complex component (SPC25), CDKN3, KIF4A, TTK, CDKN2C,
and TPX2 (all downregulated), and tankyrase 1 binding protein
1 (TNKS1BP1) (upregulated). Based on the function of the pro-
tein products of these genes, these modulations will have an in-
hibitory effect on cell proliferation. Furthermore, overexpression
of CDK1,[78] CCNB1,[79] peroxiredoxin 3 (PRDX3),[80] TOP2A,[81]
SPC25,[82] CDKN3,[83] KIF4A,[84] TTK,[85] POU class 5 homeobox
1 (POU5F1),[86] and TPX2[87] has been reported to play a role in
CRC. As the expression of these genes was downregulated, ex-
cept for POU5F1, these modulations are in favor of protection
against CRC. Overall, these results suggest that consumption of
meat containing phytochemicals may inhibit the process of cell
proliferation.
In line with these findings, linear mixed model analyses iden-
tified genes associated with exposure to phytochemicals to play
in particular a role in the regulation of the cell cycle. This was
predominantly mediated by CDK1, CDK2, BARD1, RPA1, RB1,
PCNA, and PPP1CC (Figure 4A,B). CDK1 was also identified as
central gene in the network of genes differentially expressed in
the colon of subjects consuming PHYTOMEmeat enriched with
phytochemicals, as discussed before. In addition to CDK1, also
TOP2A, CDKN2C, SETD7, CDKN3, and PRDX3, were present
in both networks (Figures 3A and 4), which demonstrates the
relevance of these gene expression changes. Both CDK1 and
CDK2 are responsible for phosphorylation of RB1, leading to its
inactivation and subsequent progression of the cell cycle.[88] In
contrast, PPP1CC, which is a positive regulator of cell growth,
is responsible for dephosphorylation of RB1, in particular after
transition of the cell cycle to the M-G1 stage.[89] Although RB1 is
regarded as a tumour suppressor gene, and loss of RB1 function
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and either low or no expression has been shown in different
tumour types, RB1 expression was upregulated in colorectal
carcinomas at both the mRNA and protein levels.[90–92] It is sug-
gested that RB1 plays a role in colorectal tumorigenesis through
functional regulation of the transcript and protein rather than
through its tumour suppressor role by gene inactivation.[92] In
addition to phosphorylation of RB1, CDK1 and CDK2 phos-
phorylate RPA1.[93] RPA1 is essential for DNA replication,
repair, and recombination. However, in numerous cancers
including CRC,[94–98] RPA1 mRNA and/or protein expression is
significantly increased and associated with a poor prognosis in
advanced cancer patients and known to stimulate proliferation
of cancer cells[97] . RPA1 is also involved in mono ubiquitination
of PCNA. In addition to its function in DNA repair, PCNA forms
complexes with all CDK-cyclin complexes during the cell cycle,
inducing both positive (among which CDK1-cyclin A and CDK2-
cyclin E) and negative effects on progression.[99] High PCNA
expression was associated with poor clinical outcome of CRC,
and could be used as a biomarker for clinical prognosis.[100] Addi-
tionally, PCNA interacts with BARD1 and in this way participates
in the cellular response to DNA damage.[101] Both CDK2-cyclin
A1/E1 and CDK1-cyclin B1 have been shown to phosphorylate
BARD1, leading to its accumulation in the M-phase.[102] In CRC
patients, loss of full length protein BARD1 was associated with
poor survival rates, and demonstrates its tumor suppressive
function.[103] Overall, these effects on the cell cycle related genes
CDK1, CDK2, RPA1, RB1, PCNA, and PPP1CC, except for the ef-
fect on BARD1 expression, are likely to result in reduced colonic
cell proliferation. In addition, they play a role in different phases
of the cell cycle, indicating that addition of phytochemicals
via meat products impacts cell proliferation at multiple levels.
Our results are in line with those reported by Bailon-Moscoso
et al.[104] who show that cell cycle related genes, in particular
CDKs and cyclins, are a key target of phytochemicals.
In summary, the whole genome gene expression analyses
identified differentially expressed genes and genes associated
with ATNC levels with or without simultaneous exposure to phy-
tochemicals, which are related to molecular pathways which may
explain cancer risk initiation after intake of processed red meat
and cancer risk prevention after intake of the PHYTOME meat.
In particular, key genes that are significantly modulated in the
colon of subjects consuming processed red meat and genes that
are associated with ATNC levels are linked to processes stimu-
lating cell proliferation and dedifferentiation, which mechanisti-
cally support cancer risk. In contrast, intake of PHYTOME meat
products demonstrated a strong response on cell cycle related
genes, which may lead to inhibition of cell proliferation, which
is likely to have a preventive effect against CRC.
This study has a number of strong points, such as the par-
allel design including a control period in order to washout the
effects induced by the processed red meat intervention before
subjects receive the PHYTOME meat. Furthermore, diets were
semi-controlled by standardizing the amount of fruits and veg-
etables intake and the concentration of nitrate in drinking water
throughout the whole study. The length of the intervention peri-
ods was sufficient and sample size was large enough in order to
expect biologically relevant effects of differentmeat interventions
including a reduction in nitrite levels on the measured markers.
A limitation of the study was the lack of a washout period at the
beginning of the study, which could have resulted in high inter-
individual differences at baseline. Furthermore, gene expression
changes and effects on O6-methyl-guanine adduct levels were
determined in colonic biopsies consisting of a mixture of differ-
ent cell populations. The contribution of each of these different
cell types on the measured effects is therefore not clear.
The outcome of this study demonstrates that exposure tomeat-
induced NOC exposure is modifiable, but in order to have a pos-
itive health impact also a successful implementation is required.
Consumers expressed a generally favorable attitude towards and
relatively strong interest in the PHYTOME meat products,[105]
but they also flagged concerns about the actual healthiness
and raised doubts whether the innovative processed meat prod-
ucts would actually be more than a marketing gimmick.[23]
These studies also demonstrated that initial responses of stake-
holders and consumers towards the PHYTOME concept are
generally favorable owing to the potential for improving pro-
cessed meat products’ health image and perceived naturalness,
respectively.[23] As this study provides the scientific evidence for
substantiation of the eventual health benefits of consuming these
innovative meat products, the potential health impact of intro-
ducing the PHYTOMEmeat products to themarket is promising.
Overall, the data from the human dietary intervention study
support the rationale behind the PHYTOME concept, that is, that
the introduction of natural bioactive compounds from plant ex-
tracts in combinationwith standard or reduced amounts of added
nitrite in processed meat products, results in the reduced forma-
tion of NOCs and less adverse reactions in the human large in-
testine. Molecular mechanisms have been identified which may
mechanistically support this finding. Furthermore, high drink-
ing water nitrate was found to stimulate endogenous nitrosation.
It is therefore crucial to take dietary intake of phytochemicals
from fruits and vegetables, as well as drinking water nitrate into
consideration when evaluating the risk of colon cancer risk as-
sociated with meat consumption. We propose that these newly
developed meat products enriched with phytochemicals may be
promising alternatives for conventional meat products, by im-
proving gut health and reducing CRC risk as a result of a de-
creased exposure to intraluminal N-nitroso compounds.
Supporting Information
Supporting Information is available from the Wiley Online Library or from
the author.
Acknowledgements
This study was financially supported by the FP7 EU-project PHYTOME
(grant number 315683). The authors gratefully acknowledge the work
of all the consortium members involved in the study. PHYTOME con-
sortium Members: Dirk Dobbelaere, CLITRAVI, Boudewijnlaan 18, 1000
Brussel, Belgium. Anneleen Vandewynkel, FENAVIAN, Federatie van de
Vleeswarenproducenten, Brusselstraat, 1702 Dilbeek, Belgium. Richard
van der Kruijk, Centrale Organisatie voor de Vleessector, Louis braille-
laan 80 2719 EK Zoetermeer. Frans Egberts, Henri van de Bilt Vleeswaren,
Goudwerf 9, 6641 TE Beuningen, the Netherlands. Jan-Hein van Helvoirt,
Foodpack B.V.Marie Curiestraat 19, 3846 BWHarderwijk, theNetherlands.
Conflict of Interest
The authors declare no conflict of interest.
Mol. Nutr. Food Res. 2021, 2001214 2001214 (14 of 17) © 2021 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH GmbH
www.advancedsciencenews.com www.mnf-journal.com
Author Contributions
The authors’ contributions were as follows: S.B. has written the original
draft of the paper. Reviewing and editing of the draft was done by T.K.,
G.K., R.S., S.B., G.H., J.H., V.W., and G.S. T.K. was responsible for concep-
tualization of the whole study in collaboration with G.K., R.S. Writing of
theMETC protocol was done by K.M. Conduction of the trial, enrollment of
subjects, assignment of participant to interventions, and specimen collec-
tion was done by K.M. and she was assisted by H.P. Sampling of biopsies
by means of endoscopy was done by A.B., assisted by C.V., and by A.M.
Supervision of the trial was carried out by T.K. Development of meat prod-
ucts was done by G.S., G.P., R.V. and the industrial consortium partners.
Analysis of ATNC was done by V.S. and G.K. Analyses of DNA adducts was
performed by P.G. Ex-vivo genotoxicity was measured by H.P. DNA extrac-
tion was done by H.P. Data analyses and statistical analyses was done by
S.B. in close collaboration with T.M., G.K., and R.S. Data interpretation
was done by S.B., T.K., G.K., P.G., and R.S. All authors contributed to and
approved the final manuscript.
Data Availability Statement
Data described in the manuscript, code book, and analytic code will be
made available upon request.
Keywords
colorectal cancer risk, gene expression, genotoxicity, human dietary inter-
vention study; N-nitroso compounds
Received: December 23, 2020
Revised: July 16, 2021
Published online:
[1] World Cancer Research Fund & American Institute for Cancer Re-
search, Diet, Nutrition, Physical Activity and Cancer: a Global Per-
spective, Second Expert Report 2007, p. 517.
[2] World Cancer Research Fund & American Institute for Cancer Re-
search Diet, Nutrition, Physical Activity and Cancer: a Global Per-
spective. Continuous Update Project Expert Report 2018.
[3] V. Bouvard, D. Loomis, K. Z. Guyton, Y. Grosse, F. E. Ghissassi,
L. Benbrahim-Tallaa, N. Guha, H. Mattock, K. Straif, International
Agency for Research on Cancer Monograph Working G, Lancet On-
col. 2015, 16, 1599.
[4] J. M. Hodgson, V. Burke, L. J. Beilin, I. B. Puddey, Am. J. Clin. Nutr.
2006, 83, 780.
[5] M. Oostindjer, J. Alexander, G. V. Amdam, G. Andersen, N. S. Bryan,
D. Chen, D. E. Corpet, S. De Smet, L. O. Dragsted, A. Haug, A. H.
Karlsson, G. Kleter, T. M. de Kok, B. Kulseng, A. L. Milkowski, R. J.
Martin, A. M. Pajari, J. E. Paulsen, J. Pickova, K. Rudi, M. Sodring,
D. L. Weed, B. Egelandsdal,Meat Sci. 2014, 97, 583.
[6] S. A. Bingham, B. Pignatelli, J. R. Pollock, A. Ellul, C. Malaveille, G.
Gross, S. Runswick, J. H. Cummings, I. K. O’Neill, Carcinogenesis
1996, 17, 515.
[7] A. J. Cross, R. Sinha, Environ. Mol. Mutagen. 2004, 44, 44.
[8] K.Wakabayashi,M.Nagao,H. Esumi, T. Sugimura,Cancer Res. 1992,
52, 2092s.
[9] G. G. Kuhnle, S. A. Bingham, Biochem. Soc. Trans. 2007, 35, 1355.
[10] E. De Mey, H. De Maere, H. Paelinck, I. Fraeye, Crit. Rev. Food Sci.
Nutr. 2017, 57, 2909.
[11] J. Haorah, L. Zhou, X.Wang, G. Xu, S. S.Mirvish, J. Agric. Food Chem.
2001, 49, 6068.
[12] M. Z.Ozel, F. Gogus, S. Yagci, J. F. Hamilton, A. C. Lewis, Food Chem.
Toxicol. 2010, 48, 3268.
[13] W. Lijinsky,Chemistry and Biology of N-nitrosocompounds, Cambridge
University Press, Cambridge 1992.
[14] W. Crowe, C. T. Elliott, B. D. Green, Nutrients 2019, 11, 2673.
[15] S. P. Trudo, D. D. Gallaher, Curr Nutr Rep 2015, 33, 33.
[16] D. G. Hebels, J. J. Briede, R. Khampang, J. C. Kleinjans, T. M. de Kok,
Toxicol. Sci. 116, 194.
[17] D. G. Hebels, D. G. Jennen, M. H. van Herwijnen, E. J. Moonen, M.
Pedersen, L. E. Knudsen, J. C. Kleinjans, T. M. de Kok, Mutagenesis
2011, 26, 753.
[18] D. G. Hebels, K. M. Sveje, M. C. de Kok, M. H. van Herwijnen,
G. G. Kuhnle, L. G. Engels, C. B. Vleugels-Simon, W. G. Mares, M.
Pierik, A. A. Masclee, J. C. Kleinjans, T. M. de Kok, Cancer Lett. 2011,
309, 1.
[19] D. G. Hebels, K. M. Sveje, M. C. de Kok, M. H. van Herwijnen, G. G.
Kuhnle, L. G. Engels, C. B. Vleugels-Simon, W. G. Mares, M. Pierik,
A. A. Masclee, J. C. Kleinjans, T. M. de Kok, Food Chem. Toxicol. 2012,
50, 95.
[20] W. Bedale, J. J. Sindelar, A. L. Milkowski,Meat Sci. 2016, 120, 85.
[21] K. O. Honikel,Meat Sci. 2008, 78, 68.
[22] L. Van Wezemael, W. Verbeke, J. O. Kugler, M. D. de Barcellos, K. G.
Grunert, Food Control 2010, 21, 835.
[23] Y. Hung, W. Verbeke, T. M. de Kok, Food Control 2016, 60, 690.
[24] B. Akesson, Biomarkers on dietary exposure to anticarcinogenic food
components and their links to mechanisms of action, ECNIS Report,
Lods, Poland 2005.
[25] S. Y. Lee, B. Munerol, S. Pollard, K. A. Youdim, A. S. Pannala, G. G.
Kuhnle, E. S. Debnam, C. Rice-Evans, J. P. Spencer, Free Radic. Biol.
Med. 2006, 40, 323.
[26] S. E. Pollard, G. G. Kuhnle, D. Vauzour, K. Vafeiadou, X. Tzounis,
M. Whiteman, C. Rice-Evans, J. P. Spencer, Biochem. Biophys. Res.
Commun. 2006, 350, 960.
[27] T. M. de Kok, S. G. van Breda, M. M. Manson, Eur. J. Nutr. 2008, 47,
51.
[28] S. G. J. van Breda, T. de Kok,Mol. Nutr. Food Res. 2017, 62, 1.
[29] C. E. de Oliveira, T. L. Stamford, N. J. Gomes Neto, E. L. de Souza,
Int. J. Food Microbiol. 2010, 137, 312.
[30] H. Bartsch, N. Frank, IARC Sci. Publ. 1996, 139, 189.
[31] S. Burt, Int. J. Food Microbiol. 2004, 94, 223.
[32] P. Colindres, M. S. Brewer, J. Sci. Food Agric. 2011, 91, 963.
[33] K. W. Cheng, F. Chen, M. Wang, Mol. Nutr. Food Res. 2007, 51,
969.
[34] M. H. Ward, E. F. Heineman, R. S. Markin, D. D. Weisenburger, Int.
J. Occup. Environ. Health 2008, 14, 193.
[35] I. R. Rowland, T. Granli, O. C. Bockman, P. E. Key, R. C. Massey,
Carcinogenesis 1991, 12, 1395.
[36] S. G. van Breda, K. Mathijs, V. Sagi-Kiss, G. G. Kuhnle, B. van der
Veer, R. R. Jones, R. Sinha, M. H. Ward, T. M. de Kok, Environ. Health
2019, 18, 87.
[37] The European Parliament and the Council of the European Union,
Official Journal of the European Union 2008, 16.
[38] M. C. Jansen, H. B. Bueno-de-Mesquita, E. J. Feskens,M. T. Streppel,
F. J. Kok, D. Kromhout, Nutr. Cancer 2004, 48, 142.
[39] C. Manach, A. Scalbert, C. Morand, C. Remesy, L. Jimenez, Am. J.
Clin. Nutr. 2004, 79, 727.
[40] G. Saccani, G. Barbieri, M. Bergamaschi, C. Blasi, M. Franceschini,
G. Parolari, Bioactive natural polyphenols in reformulated meat
products. Effect on quality traits, in: 61st International Congress of
Meat Science and Technology (ICoMST), Clermont-Ferrand, France
2015.
[41] A. Chiralt, P. Fito, J. Barat, A. Andres, C. Gonzalez-Martinez, I. Es-
criche, M. Camacho, J. Food Eng. 2001, 49, 141.
[42] European Food Safety Authority, EFSA J. 2003, 14, 1.
Mol. Nutr. Food Res. 2021, 2001214 2001214 (15 of 17) © 2021 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH GmbH
www.advancedsciencenews.com www.mnf-journal.com
[43] B. T. Cenci-Goga, M. Karama, P. Sechi, M. F. Iulietto, L. Grispoldi, R.
Selvaggini, M. Ceccarelli, S. Barbera,Meat Sci. 2018, 139, 247.
[44] G. Merialdi, M. Ramini, G. Parolari, S. Barbuti, M. A. Frustoli, R.
Taddei, S. Pongolini, P. Ardigo, P. Cozzolino, Ital. J. Food Saf. 2016,
5, 5564.
[45] R. Hughes, A. J. Cross, J. R. Pollock, S. Bingham,Carcinogenesis 2001,
22, 199.
[46] C. T. M. Rossum, E. J. M. Buurma-Rethans, F. B. C. Vennemann,
M. Beukers, H. A. M. Brants, E. J. de Boer, M. C Ocké, The Diet of
the Dutch - Results of the First Two Years of the Dutch National Food
Consumption Survey 2012–2016, National Institute for Public Health
and the Environment (RIVM), Bilthoven 2016.
[47] R. Sinha, N. Zhao, J. J. Goedert, D. A. Byrd, Y. Wan, X. Hua, A. G.
Hullings, R. Knight, S. V. Breda, K. Mathijs, T. M. de Kok, M. H.
Ward, Environ. Res. 2021, 197, 111084.
[48] G. G. Kuhnle, G. W. Story, T. Reda, A. R. Mani, K. P. Moore, J. C.
Lunn, S. A. Bingham, Free Radic. Biol. Med. 2007, 43, 1040.
[49] N. P. Singh, M. T. McCoy, R. R. Tice, E. L. Schneider, Exp. Cell Res.
1988, 175, 184.
[50] M. Pflaum, O. Will, B. Epe, Carcinogenesis 1997, 18, 2225.
[51] C. N. Hall, A. F. Badawi, P. J. O’Connor, R. Saffhill, Br. J. Cancer 1991,
64, 59.
[52] A. C. Povey, A. F. Badawi, D. P. Cooper, C. N. Hall, K. L. Harrison, P.
E. Jackson, N. P. Lees, P. J. O’Connor, G. P. Margison, J. Nutr. 2002,
132, 3518S.
[53] P. Georgiadis, S. Kaila, P. Makedonopoulou, E. Fthenou, L. Chatzi,
V. Pletsa, S. A. Kyrtopoulos, Cancer Epidemiol. Biomarkers Prev. 2011,
20, 82.
[54] R. Edgar, M. Domrachev, A. E. Lash,Nucleic Acids Res. 2002, 30, 207.
[55] G. K. Smyth, in Bioinformatics and Computational Biology Solutions
using R and Bioconductor (Eds: R. Gentleman, S. Dudoit, R. Irizarry
W. Huber, V. Carey), Springer, New York, 2005, p. 397.
[56] A. Espin-Perez, T. M. de Kok, D. G. Jennen, D. M. Hendrickx, S. De
Coster, G. Schoeters, W. Baeyens, N. van Larebeke, J. C. Kleinjans,
Carcinogenesis 2015, 36, 1154.
[57] M. Chadeau-Hyam, R. C. Vermeulen, D. G. Hebels, R. Castagne, G.
Campanella, L. Portengen, R. S. Kelly, I. A. Bergdahl, B. Melin, G.
Hallmans, D. Palli, V. Krogh, R. Tumino, C. Sacerdote, S. Panico, T.
M. de Kok, M. T. Smith, J. C. Kleinjans, P. Vineis, S. A. Kyrtopoulos,
Ann. Oncol. 2014, 25, 1065.
[58] A. Kamburov, K. Pentchev, H. Galicka, C. Wierling, H. Lehrach, R.
Herwig, Nucleic Acids Res. 2011, 39, D712.
[59] P. Shannon, A.Markiel, O.Ozier, N. S. Baliga, J. T.Wang, D. Ramage,
N. Amin, B. Schwikowski, T. Ideker, Genome Res. 2003, 13, 2498.
[60] D. G. Hebels, K. J. Brauers, M. H. van Herwijnen, P. A. Georgiadis,
S. A. Kyrtopoulos, J. C. Kleinjans, T. M. de Kok, Toxicol. Lett. 2011,
207, 232.
[61] J. Winter, L. Nyskohus, G. P. Young, Y. Hu, M. A. Conlon, A. R. Bird,
D. L. Topping, R. K. Le Leu, Cancer Prev. Res. (Phila) 2011, 4, 1920.
[62] L. S. Nyskohus, A. J. Watson, G. P. Margison, R. K. Le Leu, S. W. Kim,
T. J. Lockett, R. J. Head, G. P. Young, Y. Hu,Mutat Res. 2013, 758, 80.
[63] C. T. Supuran, Nat Rev Drug Discov 2008, 7, 168.
[64] G. Z. Yang, L. Hu, J. Cai, H. Y. Chen, Y. Zhang, D. Feng, C. Y. Qi, Y.
X. Zhai, H. Gong, H. Fu, Q. P. Cai, C. F. Gao, BMC Cancer 2015, 15,
209.
[65] R. Del Giudice, D. M. Monti, E. Truppo, A. Arciello, C. T. Supuran,
G. De Simone, S. M. Monti, Biol. Chem. 2013, 394, 1343.
[66] T. Ohashi, M. Idogawa, Y. Sasaki, H. Suzuki, T. Tokino, Mol. Cancer
Res. 2013, 11, 1554.
[67] Y. Shen, L. Zhong, S. Johnson, D. Cao, Chem. Biol. Interact. 2011,
191, 192.
[68] E. S. Kropotova, R. A. Tychko, O. L. Zinov’eva, A. F. Zyrianova, S. L.
Khankin, V. L. Cherkes, V. A. Aliev, S. F. Beresten, N. Oparina, T. D.
Mashkova,Mol. Biol. (Mosk) 2010, 44, 243.
[69] X. Zu, R. Yan, J. Pan, L. Zhong, Y. Cao, J. Ma, C. Cai, D. Huang, J. Liu,
F. L. Chung, D. F. Liao, D. Cao,Mol. Carcinog. 2017, 56, 118.
[70] M. Ohta, M. Seto, H. Ijichi, K. Miyabayashi, Y. Kudo, D. Mohri, Y.
Asaoka, M. Tada, Y. Tanaka, T. Ikenoue, F. Kanai, T. Kawabe, M.
Omata, Gastroenterology 2009, 136, 206.
[71] C. Kosinski, V. S. Li, A. S. Chan, J. Zhang, C. Ho, W. Y. Tsui, T. L.
Chan, R. C. Mifflin, D. W. Powell, S. T. Yuen, S. Y. Leung, X. Chen,
Proc. Natl. Acad. Sci. U S A 2007, 104, 15418.
[72] X. C. He, J. Zhang, W. G. Tong, O. Tawfik, J. Ross, D. H. Scoville,
Q. Tian, X. Zeng, X. He, L. M. Wiedemann, Y. Mishina, L. Li, Nat.
Genet. 2004, 36, 1117.
[73] I. Amelio, F. Cutruzzola, A. Antonov, M. Agostini, G. Melino, Trends
Biochem. Sci. 2014, 39, 191.
[74] S. Stauffer, Y. Zeng, J. Zhou, X. Chen, Y. Chen, J. Dong, Cell Signal
2017, 39, 74.
[75] J. Zou, W. Kuang, J. Hu, H. Rao, Biochem. Biophys. Res. Commun.
2017, 488, 247.
[76] P. K. Singh, A. K. Srivastava, D. Dalela, S. K. Rath, M. M. Goel, M. L.
Bhatt, Immunobiology 2014, 219, 469.
[77] T. Ohashi, S. Komatsu, D. Ichikawa, M. Miyamae, W. Okajima, T.
Imamura, J. Kiuchi, T. Kosuga, H. Konishi, A. Shiozaki, H. Fujiwara,
K. Okamoto, H. Tsuda, E. Otsuji, Br. J. Cancer 2017, 116, 218.
[78] W. Gan, H. Zhao, T. Li, K. Liu, J. Huang, Oncotarget 2017, 8, 71618.
[79] C. Ye, J. Wang, P. Wu, X. Li, Y. Chai, Oncotarget 2017, 8, 2224.
[80] I. S. Song, Y. J. Jeong, J. Han, BMB Rep. 2015, 48, 539.
[81] A. Coss, M. Tosetto, E. J. Fox, B. Sapetto-Rebow, S. Gorman, B. N.
Kennedy, A. T. Lloyd, J. M. Hyland, D. P. O’Donoghue, K. Sheahan,
D. T. Leahy, H. E. Mulcahy, J. N. O’Sullivan, Cancer Lett. 2009, 276,
228.
[82] N. Kaneko, K. Miura, Z. Gu, H. Karasawa, S. Ohnuma, H. Sasaki,
N. Tsukamoto, S. Yokoyama, A. Yamamura, H. Nagase, C. Shi-
bata, I. Sasaki, A. Horii, Biochem. Biophys. Res. Commun. 2009, 390,
1235.
[83] C. Yang, J. J. Sun, Asian Pac. J. Cancer Prev. 2015, 16, 965.
[84] Y. Matsumoto, M. Saito, K. Saito, Y. Kanke, Y. Watanabe, H.
Onozawa, S. Hayase, W. Sakamoto, T. Ishigame, T. Momma, K. Ku-
mamoto, S. Ohki, S. Takenoshita, Oncol. Lett. 2018, 15, 2188.
[85] M. Tarnowski, M. Czerewaty, A. Deskur, K. Safranow, W. Marlicz, E.
Urasinska, M. Z. Ratajczak, T. Starzynska, Dis. Markers 2016, 2016,
1987505.
[86] N.Miyoshi, S. Fujino, M. Ohue,M. Yasui, Y. Takahashi, K. Sugimura,
A. Tomokuni, H. Akita, S. Kobayashi, H. Takahashi, T. Omori, H.
Miyata, M. Yano, Surg. Today 2018, 48, 709.
[87] P. Wei, N. Zhang, Y. Xu, X. Li, D. Shi, Y. Wang, D. Li, S. Cai, J. Transl.
Med. 2013, 11, 313.
[88] Z. Shao, P. D. Robbins, Oncogene 1995, 10, 221.
[89] J. Figueiredo, E. da Cruz, M. Fardilha, Curr. Cancer Drug Targets 2014,
14, 2.
[90] R. Gope, M. A. Christensen, A. Thorson, H. T. Lynch, T. Smyrk, C.
Hodgson, D. M. Wildrick, M. L. Gope, B. M. Boman, J. Natl. Cancer
Inst. 1990, 82, 310.
[91] P. Kanavaros, K. Stefanaki, K. Valassiadou, J. Vlachonikolis, M.
Mavromanolakis, M. Vlychou, S. Kakolyris, V. Gorgoulis, M. Tzardi,
V. Georgoulias,Med. Oncol. 1999, 16, 23.
[92] P. S. Lai, P. Y. Cheah, P. Kadam, C. L. Chua, D. K. Lie, H. H. Li, K. W.
Eu, F. Seow-Choen, A. S. Lee, Int. J. Cancer 2006, 119, 1061.
[93] Z. Q. Pan, A. Amin, J. Hurwitz, J. Biol. Chem. 1993, 268,
20443.
[94] D. J. Zhang, J. Xiang, X. Wang, J. Wang, J. C. Xiao, W. Xu, H. Xu, Y.
Xin, L. Z. Zhang, D. S. Pei, J. N. Zheng, Y. M. Gu, Panminerva Med.
2015, 57, 183.
[95] G. Levidou, K. Ventouri, A. Nonni, H. Gakiopoulou, A. Bamias, M.
Sotiropoulou, I. Papaspirou, M. A. Dimopoulos, E. Patsouris, P. Ko-
rkolopoulou, Int. J. Gynecol. Pathol. 2012, 31, 319.
Mol. Nutr. Food Res. 2021, 2001214 2001214 (16 of 17) © 2021 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH GmbH
www.advancedsciencenews.com www.mnf-journal.com
[96] G. Levidou, H. Gakiopoulou, N. Kavantzas, A. A. Saetta, M. Karlou,
P. Pavlopoulos, I. Thymara, K. Diamantopoulou, E. Patsouris, P. Ko-
rkolopoulou, BJU Int. 2011, 108, E59.
[97] J. Wang, T. Yang, H. Chen, H. Li, S. Zheng, Biochem. Biophys. Res.
Commun. 2018, 498, 424.
[98] N. Givalos,H.Gakiopoulou,M. Skliri, K. Bousboukea, A. E. Konstan-
tinidou, P. Korkolopoulou, M. Lelouda, G. Kouraklis, E. Patsouris, G.
Karatzas,Mod. Pathol. 2007, 20, 159.
[99] G. Maga, U. Hubscher, J. Cell Sci. 2003, 116, 3051.
[100] H. Zhou, T. Huang, Y. Xiong, L. Peng, R. Wang, G. J. Zhang,Medicine
(Baltimore) 2018, 97, e13752.
[101] F. E. Kleiman, J. L. Manley, Science 1999, 285, 1576.
[102] A. D. Choudhury, H. Xu, A. P. Modi, W. Zhang, T. Ludwig, R. Baer, J.
Biol. Chem. 2005, 280, 24669.
[103] J. C. Sporn, T. Hothorn, B. Jung, Clin. Cancer Res. 2011, 17, 5451.
[104] N. Bailon-Moscoso, G. Cevallos-Solorzano, J. C. Romero-Benavides,
M. I. Orellana, Curr. Genomics 2017, 18, 106.
[105] Y. Hung, T. M. de Kok, W. Verbeke,Meat Sci. 2016, 121, 119.
Mol. Nutr. Food Res. 2021, 2001214 2001214 (17 of 17) © 2021 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH GmbH
